Found 4 hits in this display Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Lysophosphatidic acid receptor 1
(Homo sapiens (Human)) | BDBM251682
(US10100018, Example 18 | US9464060, 18)Show SMILES OC(=O)c1ccc(CN(CC2CC2c2ccccc2)C(=O)c2ccc(Oc3ccccc3F)cc2)cc1 Show InChI InChI=1S/C31H26FNO4/c32-28-8-4-5-9-29(28)37-26-16-14-23(15-17-26)30(34)33(19-21-10-12-24(13-11-21)31(35)36)20-25-18-27(25)22-6-2-1-3-7-22/h1-17,25,27H,18-20H2,(H,35,36) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited
US Patent
| Assay Description
Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... |
US Patent US9464060 (2016)
BindingDB Entry DOI: 10.7270/Q23R0RT0 |
More data for this
Ligand-Target Pair | |
Lysophosphatidic acid receptor 1
(Homo sapiens (Human)) | BDBM251682
(US10100018, Example 18 | US9464060, 18)Show SMILES OC(=O)c1ccc(CN(CC2CC2c2ccccc2)C(=O)c2ccc(Oc3ccccc3F)cc2)cc1 Show InChI InChI=1S/C31H26FNO4/c32-28-8-4-5-9-29(28)37-26-16-14-23(15-17-26)30(34)33(19-21-10-12-24(13-11-21)31(35)36)20-25-18-27(25)22-6-2-1-3-7-22/h1-17,25,27H,18-20H2,(H,35,36) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited
US Patent
| Assay Description
Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... |
US Patent US10100018 (2018)
BindingDB Entry DOI: 10.7270/Q2PR7Z0N |
More data for this
Ligand-Target Pair | |
Lysophosphatidic acid receptor 1
(Homo sapiens (Human)) | BDBM251682
(US10100018, Example 18 | US9464060, 18)Show SMILES OC(=O)c1ccc(CN(CC2CC2c2ccccc2)C(=O)c2ccc(Oc3ccccc3F)cc2)cc1 Show InChI InChI=1S/C31H26FNO4/c32-28-8-4-5-9-29(28)37-26-16-14-23(15-17-26)30(34)33(19-21-10-12-24(13-11-21)31(35)36)20-25-18-27(25)22-6-2-1-3-7-22/h1-17,25,27H,18-20H2,(H,35,36) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | 25 |
Takeda Pharmaceutical Company Limited
US Patent
| Assay Description
Engagement of the LPA1 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium i... |
US Patent US10100018 (2018)
BindingDB Entry DOI: 10.7270/Q2PR7Z0N |
More data for this
Ligand-Target Pair | |
Lysophosphatidic acid receptor 5
(Homo sapiens (Human)) | BDBM251682
(US10100018, Example 18 | US9464060, 18)Show SMILES OC(=O)c1ccc(CN(CC2CC2c2ccccc2)C(=O)c2ccc(Oc3ccccc3F)cc2)cc1 Show InChI InChI=1S/C31H26FNO4/c32-28-8-4-5-9-29(28)37-26-16-14-23(15-17-26)30(34)33(19-21-10-12-24(13-11-21)31(35)36)20-25-18-27(25)22-6-2-1-3-7-22/h1-17,25,27H,18-20H2,(H,35,36) | UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | 37 |
Takeda Pharmaceutical Company Limited
US Patent
| Assay Description
Engagement of the LPA5 receptor by its ligand, oleoyl-L-α-lysophosphatidic acid (LPA), leads to the release of intracellular stores of calcium into ... |
US Patent US9464060 (2016)
BindingDB Entry DOI: 10.7270/Q23R0RT0 |
More data for this
Ligand-Target Pair | |